Subsequently, it was reported that miR-216b increased the expression of Bcl-2 by reducing apoptosis and promoting chemotherapy resistance in NSCLC cells (Vu et al., 2020). The gene discussed is BCL2; the disease is non-small cell lung carcinoma.